FDA News & Notes - Week of January 9, 2012
SILVER SPRING, Md., Jan. 9, 2012 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of January 9, 2012.
(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)
FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.
Meetings, Workshops and Congressional Testimony:
Wednesday, 1/11 - The Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee makes recommendations and votes on the premarket approval application by Torax Medical Inc. for the LINX Reflux Management System to treat gastroesophageal reflux disease. 8 a.m., Hilton Washington DC North/Gaithersburg, 620 Perry Parkway, Salons A, B, C, and D, Gaithersburg, Md.
Press Office Contact: Morgan Liscinsky, 301-796-0397, morgan.liscinsky@fda.hhs.gov
Wednesday, 1/18 - First day of a three-day public meeting of the Tobacco Products Scientific Advisory Committee. On Jan. 18, from 8:00 a.m. to 1:00 p.m., the meeting will be closed to permit discussion and review of trade secret and/or confidential commercial information. The meeting will be open to the public on Jan. 18, from 2 p.m. to 5 p.m., on Jan. 19, from 8 a.m. to 5 p.m., and on Jan. 20, from 8 a.m. to 4 p.m. Meeting will be webcast. 9200 Corporate Boulevard, Rockville, Md.
Press Office Contact: Michelle Bolek, 301-796-2973, michelle.bolek@fda.hhs.gov
FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, fdaopa@fda.hhs.gov
List of FDA press officers and beats
More Resources:
FDA News and Events
FDA Photos (Flickr)
Consumer Health Information
SOURCE U.S. Food and Drug Administration